ALDEYRA THERAPEUTICS INC's ticker is ALDX and the CUSIP is 01438T106. A total of 120 filers reported holding ALDEYRA THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $336,939 | -81.8% | 50,440 | -77.1% | 0.00% | -100.0% |
Q2 2023 | $1,850,247 | +2933.2% | 220,530 | +1350.9% | 0.00% | – |
Q4 2021 | $61,000 | -54.1% | 15,200 | 0.0% | 0.00% | – |
Q3 2021 | $133,000 | -22.7% | 15,200 | 0.0% | 0.00% | – |
Q2 2021 | $172,000 | +421.2% | 15,200 | +12.6% | 0.00% | – |
Q1 2020 | $33,000 | -57.7% | 13,500 | 0.0% | 0.00% | – |
Q4 2019 | $78,000 | +9.9% | 13,500 | 0.0% | 0.00% | – |
Q3 2019 | $71,000 | -12.3% | 13,500 | 0.0% | 0.00% | – |
Q2 2019 | $81,000 | – | 13,500 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Prosight Management, LP | 908,488 | $6,232,000 | 2.88% |
Knoll Capital Management, LLC | 569,405 | $3,906,000 | 2.66% |
Mesirow Financial Investment Management, Inc. | 64,698 | $443,828,000 | 1.40% |
Ghost Tree Capital, LLC | 650,000 | $4,459,000 | 0.99% |
Johnson & Johnson Innovation - JJDC, Inc. | 594,834 | $4,081,000 | 0.53% |
Perceptive Advisors | 6,285,458 | $43,118,000 | 0.46% |
Affinity Asset Advisors, LLC | 100,000 | $686,000 | 0.36% |
ACUTA CAPITAL PARTNERS, LLC | 192,500 | $1,321,000 | 0.36% |
Avidity Partners Management LP | 1,435,000 | $9,844,000 | 0.32% |
APOGEM CAPITAL LLC | 55,821 | $383,000 | 0.26% |